The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
On 19.03.2014, the European Generic Medicines Association (EGA), whose member is BGPharmA, carried out its tenth annual Legal Affairs Forum and appealed to the EU to remove the obstacles to competition and free trade on pharmaceuticals markets by implementation of reasonable reforms regarding intellectual property rules in the pharmaceutical sector.
As a member of BHPharmA, Sopharma took part in a press conference of the Association on 27.03. on „What are the major threats to access to medicines of patients in Bulgaria ”, in connection with the proposed changes in the Health Insurance Act (HIA). These changes refer to the business of pharmaceutical manufacturers and would lead to its hindrance, even to delisting of some medicines on our market.
According to information of BGPharmAbasedonthe 2014 report of the World Bank, pharmaceutical industry in Bulgaria plays a structurally defining role for the national economy. Generic pharmaceutical industry at European level provides over 150 000 work places and saves costs to the amount of 35 milliard Euro every year.
The annual student case study competition called F.I.R.M.A. (Focus, Innovation, Realisation, Motivation, Ambition), organised by the Business Club of St. Kliment Ohridski University of Sofia, introduces the students to real work situations in partnership with different successful companies. Thisyear, partners of the initiative are Overgas Inc., Sopharma, Methodia AD and Network of UN Global Contract in Bulgaria.
Sopharma AD, jointly with St. Ivan Rilski Charitable Association, donated first aid kits with essential medicines to the International Organization for Migration.
